Sponsored Content
Advertisement
Articles by Sponsored Content
Vincent Herrin, MD - University of Mississippi Medical Center Jackson, Mississippi
Advertisement
Latest Updated Articles
- POLIVY + BR: A Therapeutic Option Granted Accelerated Approval for R/R 3/L+DLBCL, NOS
Published: February 2nd 2020 | Updated:
- The Proposed Mechanism of Action of POLIVY for R/R DLBCL, NOS
Published: February 1st 2020 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
